Log In

The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration

Files

stolk_07_theassociationbetweenexposure.pdf (3.59 MB)

Publication date

2007

Authors

Stolk, PieterISNI 0000000397161048
Souverein, PatrickORCID 0000-0002-7452-0477ISNI 0000000392263686
Leufkens, BertISNI 0000000392454327
Weil, J.G.
Egberts, ToineORCID 0000-0003-1758-7779ISNI 0000000392745722
Heerdink, RobORCID 0000-0002-5946-7209ISNI 0000000394315283

Editors

Advisors

Supervisors

DOI

Document Type

Article

Metadata

Show full item record

Collections

Utrecht University Repository
Open Access logo

License

Abstract

Keywords

Econometric and Statistical Methods: General, Geneeskunde (GENK), Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Geneeskunde(GENK), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, Pharmacology, SDG 3 - Good Health and Well-being

Citation

Stolk, P, Souverein, P C, Leufkens, H G M, Weil, J G, Egberts, A C G & Heerdink, E R 2007, 'The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration', Pharmacopsychiatry, vol. 40, pp. 111-115.

URI

http://hdl.handle.net/1874/27376